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ABSTRACT

Currently, DNA profiling is the gold standard to identify an individual. However,
determining body fluid origin is important in criminal investigations, offering additional
information surrounding the circumstances of a crime. However, crime labs can only definitively
identify blood and semen and presumptively saliva using techniques that consume time and
sample and do not simultaneously identify all forensically relevant body fluids. This causes
many crime labs to want to bypass body fluid identification altogether. Therefore, advances into
more definitive molecular-based body fluid methods are necessary. One such technique is
mRNA profiling because it provides a highly sensitive and specific approach to definitively
identifying all relevant body fluids in parallel. Although advancements have been made,
improvements to mRNA profiling methodologies still need to be researched such as 1) possible
mRNA recovery from established DNA workflows and 2) possible integration of mRNA
profiling into an upfront male DNA screening assay for triaging sexual-assault evidence likely to
contain male DNA and reduce/eliminate a significant bottleneck in the standard DNA workflow
of microscopic sperm identification. This study was designed to address these two issues by
evaluating a novel way to recover RNA, for body fluid identification, from the waste fractions of
a PrepFiler™ DNA extraction, and from the DNA extracts directly. Next, this study aimed to
provide a relatively quick molecular-based approach for screening sexual-assault evidence. It
involves extraction of RNA using the Dynabeads™ mRNA DIRECT™ Kit, while saving the
extraction waste fractions for downstream male-DNA quantitation and STR profiling. The RNA
iii

is then used in a rapid and sensitive 1-step combined reverse transcription-HRM assay to
positively detect the presence of sperm. Both non-conventional co-extraction methods
successfully addressed current body fluid identification challenges and allowed for easy
integration into existing workflows when single sourced, mixture and mock casework samples
were analyzed.
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CHAPTER ONE: INTRODUCTION

Routinely, evidence gathered from a crime scene, believed to contain human biological
material, is analyzed for human genomic DNA to identify the contributor(s) of a stain. Although
DNA profiling is the gold standard [1] it has also become increasingly important that crime labs
determine the origin of the stain to aid investigators in better understanding the circumstances
surrounding a crime. In circumstances such as sexual-assaults, it is important to not only identify
those involved but to prove the presence of male specific body fluids such as semen and even
more specifically sperm. In some crime labs, evidence goes through a preliminary screening
process to confirm the presence of specific body fluids, but they are often not confirmatory for
all relevant body fluids such as saliva, vaginal secretions, menstrual blood, and skin. These
techniques are also very time and sample consuming, do not allow simultaneous detection of all
forensically relevant body fluids, and are not easily integrated into DNA workflows [2, 3].
Therefore, some crime labs are aiming to bypass body fluid identification altogether and go
straight into DNA analysis, which can be detrimental in court if the evidence is misrepresented
[4].
Currently, crime labs use chemical or enzymatic assays to presume the presence of some
forensically relevant body fluids [1, 3, 5-7]. These include presumptive body fluid testing for
blood (Phenolphthalein, Luminol, Hemastix® (Sirchie Youngsville, NC) [1, 3, 5-7]), semen (acid
phosphatase, and ABAcard® p30 (Abacus Diagnostics® West Hills, CA) [1, 3, 5-8]), and saliva
(Phadebas® Amylase test (Magle Life Sciences Cambridge, MA), SALIgAE® (Abacus
Diagnostics®), RSID™ Saliva Kit (Independent Forensics Lombard, IL) [1, 3, 5-7]), but most
often these tests are not sensitive enough and can produce false-positives in the presence of other
1

body fluids. Although there are confirmatory tests for blood (ABAcard® HemaTrace® (Abacus
Diagnostics®) or RSID™-blood test (Independent Forensics Lombard, IL) [1, 3, 5-7]) and semen
(microscopic examination with Christmas Tree staining [1, 6, 8-10]), they are very time
consuming (particularly microscopic identification of sperm), use a lot of sample and do not
allow for the positive identification of saliva, vaginal secretions or menstrual blood [1, 3, 5-7].
Depending on the nature of the crime, a positive identification of male specific body
fluids such as spermatozoa, semen or seminal fluid can play a key role in determining the
circumstances surrounding a crime. When a victim believes he or she has been sexually assaulted
a medical professional generally uses a sexual assault kit (SAK) to collect evidence that could
have been left behind. These kits vary, but often include swabs and collection envelopes for any
loose biological materials or undergarments [11]. In sexual assault crimes involving sexual
intercourse, whether oral, vaginal or anal, it is important to establish the body fluids that are
present on pieces of evidence. Often times, SAKs are first screened for the presence of these
body fluids and if there is not a positive identification, further testing might not be performed [6,
11].
Current male DNA screening methods include testing for the presence of seminal acid
phosphatase, an enzyme present in semen [6, 7], or a rapid immunochromatographic assay for
the presence of prostate-specific antigen (PSA) that is found in semen [8, 9]. Although these tests
are able to rapidly screen SAK evidence, they are often times used presumptively because they
do not confirm the presence of spermatozoa and have a tendency to produce false positives when
in the presence of some vaginal specific enzymes or proteins [1, 6, 8, 9]. Currently, the only
confirmatory tests performed in crime labs to determine the presence of human spermatozoa is
the microscopic analysis of sperm cells using a Christmas tree stain. Microscopic examination of
2

sperm entails an analyst physically counting the total number of sperm present on a slide that has
been stained with dyes for better visualization of single cells (Nuclear Fast Red and
picroindigocarmine, hematoxylin-eosin [12] or SPERM HY-LITER™ (Independent Forensics)
[13]. This method is by no means rapid, sometimes subjective, and must often times be used in
combination with the presumptive tests when little to no sperm is present or are difficult to
distinguish amongst larger epithelial cells to ensure the presence of male DNA or that the semen
donor is vasectomized (azoospermic) [6, 14, 15].
Consequently, a major bottleneck with microscopic sperm identification is that it causes
major backlogs in the processing of SAKs as well as other sexual-assault related evidence [14].
Because a large amount of a crime lab’s backlog includes SAKs and other sexual assault-related
evidence that has been received but has not yet been processed [11, 16], the federal government
addressed the problem and made funding available for research into addressing the backlog.
Under the Sexual Assault Forensic Evidence Reporting Act of 2013, DNA evidence specifically
from a SAK or related sexual-assault crime must be processed quickly while still following
proper protocol to ensure quality analysis [17]. However, because some crime labs want to
move away from traditional body fluid ID, there is a significant need for more rapid molecularbased techniques in order to provide critical sample information in a more timely manner [2, 3,
18].
In recent years, there have been many advancements in the development of molecularbased body fluid assays that aim to improve upon currently used body fluid identification
methods. Some such studies include the use of tissue-specific epigenomic modifications to study
gene expression patterns through DNA methylation [5, 19, 20], the exploration of tissue-specific
post-translational modifications using protein-biomarkers [21], and the use of body fluid or
3

tissue specific messenger RNA transcripts, better known as mRNA profiling [1-7, 10, 18, 19, 2228]. Amongst these methods, mRNA profiling has been well studied in regard to body fluid
identification and shows great promise for integration into current DNA workflows [25, 29, 30].
RNA, specifically messenger RNA, is transcribed directly from DNA and plays an active
role in controlling gene expression that further directs protein synthesis. In certain cells, specific
genes are expressed, turned on, and others are turned off allowing for the synthesis of certain
proteins. The fluids and tissues that are of interest in forensics, such as semen, blood, menstrual
blood, vaginal secretions, saliva, and skin [1-4, 10, 22-29, 31, 32] contain a mixture of multiple
cell types that collectively encompass the multicellular transcriptome. It is this multicellular
transcriptome that can be targeted for mRNA profiling because it is unique to each body fluid or
tissue. Although, in biochemical applications, RNA is generally known to be highly degradative
due the 2’-OH in ribose and the presence of ribonucleases, it has been found to be highly stable
in biological evidence [1, 2, 6, 33]. Once mRNA is reversely transcribed back into its original
complementary DNA (cDNA) transcript, the transcripts can be amplified using techniques (PCR
amplification, capillary electrophoresis (CE)) and equipment that are used routinely in
operational crime laboratories, thus reducing the need for additional training or specialized
equipment. One such method uses multiplex reverse transcription-polymerase chain reaction
(RT-PCR) followed by CE [2, 4, 22-29], to detect the amplified product once fluorescentlylabeled primers are incorporated (Not yet published; Table 3) to target each mRNA sequence.
They are detected much like how short tandem repeats (STRs) are detected in DNA profiling.
Another method that is not typically used for mRNA profiling but has been well studied for its
use in variant detection is High Resolution Melt (HRM) analysis [29, 34, 35]. Recent research
has proven the ability to monitor a gene-specific marker in real time with the use of non4

fluorescently labeled primers and a saturating intercalating fluorescent dye [34, 35] such as Eva
Green that preferentially binds to double stranded DNA. Because the primers are unlabeled, in
contrast to CE based methods that use fluorescently labeled primers [22, 26, 27, 31, 32, 34, 35],
it allows a lower cost alternative that provides the same or even greater sensitivity. When a
reverse transcription combined HRM assay is performed, the simultaneous conversion of mRNA
to cDNA followed by a traditional PCR reaction can be monitored in real-time. Followed by a
final melting stage, the level of fluorescence can once more be monitored in real-time and the
temperature at which the two strands dissociate 50% can be detected. The real-time software
takes the negative first derivative of fluorescence (F) in relation to temperature (T)(-dF/dT) [34,
35] and produces a unique melt-curve that is amplimer (also referred to as amplicon) sequence
and assay specific. In a single-plex assay containing one gene-specific primer there is a single
melting curve, but multiplex assays are also possible that can allow for multiple melting curves
to be detected simultaneously [26, 27, 34, 35].
While the application of RNA in body fluid identification has shown to be robust, it is
essential that DNA and RNA can be co-extracted from the same portion of stain, thus reducing
the effect stain composition may have on analysis and can easily be adapted to current DNA
workflows. Recent studies into DNA/RNA co-isolation and co-extraction techniques have
proven that both RNA and DNA can be extracted with the use of a single stain [1, 7, 22, 25, 27,
30-33, 36] but do not integrate well into current DNA workflows. A study performed by the
Institute of Environmental Science and Research (ESR), New Zealand, has recently evaluated the
ability to recover RNA from saved extraction waste fractions using the DNA IQ system [18, 30].
Although recovery efforts allow for ideal integration into current DNA workflows, the DNA IQ
system is not directly applicable to all crime labs in the United States. With the ability to
5

integrate RNA recovery into current DNA workflows, mRNA profiling can be applied in other
ways that would not require any additional modifications, and therefore, validation of existing
DNA methods and also uniquely in ways that could result in reductions in evidence backlogs.
This includes research not only into other possible ways to recover RNA without interrupting the
flow of DNA analysis but to also provide a possible upfront sperm detection that would help to
rapidly screen SAK evidence while eliminating the major bottle neck of microscopic sperm ID.
Furthermore, the detection of sperm provides a strong indication of sexual intercourse taking
place while also indicating the presence of y-typeable male DNA to better identify male
contributor(s).
Therefore, the first goal of this study was to evaluate the ability of another commonly
used DNA extraction procedure to recover RNA using extraction waste fractions. Most crime
labs aim to streamline their DNA evidence workflows to include a more automated system to
increase productivity and reduce possible errors [14, 37]. As a result, they will typically use
commercially available kits. These may include the Promega DNA IQ kit, QIAGEN EZ1
Investigator kit, or the Applied Biosystems™ PrepFiler™ Forensic DNA Extraction Kit.
Although all three of these kits listed are able to be performed manually or through automation
[37] a validation study determined that PrepFiler™ was able to extract more total DNA when
compared to the other kits [38]. In 2009, the PrepFiler™ Forensic DNA Extraction Kit was
validated and implemented into crime labs across the country for the isolation of genomic DNA
using a wide range of biological samples [38]. As previously stated, the kit allows for both a
manual and automated DNA extraction using magnetic beads that bind DNA through an
“optimized multicomponent surface chemistry” permitting inhibitors to be washed away. Per
protocol, the flow through during these bead washing steps is normally discarded [39]. This
6

study investigates the ability of the PrepFiler™ Forensic DNA extraction kit to extract DNA
while simultaneously saving the extraction wash step waste fractions to check for future presence
of co-extracted RNA.
Throughout the study, several body fluid samples were manually extracted according to
protocol [39] and the individual waste fractions were saved and purified using the PureLink
RNA Mini Kit [40]. mRNA body fluid markers were targeted using a multiplex reverse
transcription-PCR assay [unpublished, 10-plex primer set used in-house] and detected using
capillary electrophoresis. By saving the first lysate waste fraction, all forensically relevant body
fluids including blood, saliva, menstrual blood, vaginal secretions and semen were able to be
detected. A major advantage to this method is the ability to save the waste fraction without
altering the manual DNA extraction and does not seem to hinder the quality or quantity of the
DNA extracted. In addition, it was discovered that body fluid identification was also possible
without purification, using mRNA present in the primary DNA extract itself. Analysts would
therefore have the ability to take a small aliquot of their DNA extract and perform the traditional
mRNA profiling analysis process as previously described. Both methods, whether saving the
waste fractions of a DNA extraction, or using the DNA extract itself, allow for possible RNA
recovery and downstream mRNA profiling applications.
The second goal of this study was to address another major challenge in current DNA
workflows by developing a rapid upfront male DNA screening method to triage sexual assault
evidence while integrating a sperm ID using mRNA profiling. Recently, a rapid male screening
assay was described that could provide an upfront detection of male DNA using a rapid lysis
followed by DNA quantitation to identify the presence of male DNA [41]. Although this method
can provide a triage for sexual assault evidence, it does not provide the confirmatory
7

identification of sperm which is a major bottleneck previously discussed. Another quantitationbased method has been developed that aims to eliminate the need for a microscopic sperm
identification and infers the presence of sperm from the detection of a significant amounts of
male DNA in the sperm fraction of differential extractions [42]. While useful, it does not
incorporate a definitive identification of sperm which may be a challenge for some laboratories.
Thus, this study aims to integrate mRNA profiling into an upfront detection for male DNA,
providing not only a rapid way to screen sexual-assault evidence for the presence of male DNA,
but to uniquely provide a definitive identification of sperm, thus reducing or eliminating the
challenging and time-consuming microscopic identification of sperm.
Since the co-extraction method developed in this work allowed for successful detection
of all forensically relevant body fluids using purified extraction waste, it was a possibility that a
similar method could be used to not only detect male DNA, but also permit recovery of male
DNA profiles as well as sperm identification using mRNA profiling. The current work paired a
rapid RNA extraction with a 1-step combined RT-HRM assay for the detection of the sperm
specific protein Protamine 2 (PRM2) [10]. Figure 8 represents the potential work flow for this
rapid male DNA screening assay and the extraction protocol, much like the assays previously
discussed, allows for the analyst to save the lysis buffer waste fraction for downstream DNA
analysis. The Dynabeads® mRNA Direct kit (Invitrogen® by ThermoFisher) allows for the
simple but rapid isolation of pure, intact polyadenylated (polyA) mRNA while using a very small
amount of sample. The rapidly lysed cells release the mRNA and covalently bind to oligo (dT)25
beads that bind to the polyA tails present in all eukaryotic mRNAs [43]. Like in the previous
study, the normally discarded waste fractions were saved and provided an upfront detection of
male DNA, indicated by a male quant. Next, RT-HRM analysis was performed using the Power
8

SYBR® Green RNA-to-CT™ 1-Step Kit (Applied Biosystems™ Foster City, CA) to analyze
mRNA extracts for detection of sperm using PRM2. Successful detection of sperm was
represented by the presence of a single distinct PRM2 melt peak at a Tm of 82˚C. Experimental
analysis of single donor semen samples and vaginal-semen mixture samples, extracted using the
mRNA Direct kit, supported the detection of sperm at the expected melting temperature with no
cross-reactivity with other body fluids. Once samples were successfully screened for male DNA
and analyzed for the presence or absence of sperm, the saved lysis buffer/lysate waste fraction
was able to be used for downstream male DNA profiling. The mRNA Direct assay allowed for a
simultaneous rapid male DNA detection and upon successful screening, detection of sperm and
male Y-STRs in as little as 1 µL of semen, with no further purification needed.
The goal of this study was to provide methodological improvements to mRNA profiling
for better integration into DNA workflows. Although more work needs to be performed to ensure
this method is compatible with an automated DNA extraction, the successful recovery of RNA in
both purified DNA extraction waste and un-purified DNA extracts, permitted successful
integration of mRNA profiling into established DNA workflows without altering DNA recovery.
Next, to improve SAK backlogs and reduce or eliminate the bottleneck of microscopic sperm ID,
it was important to provide an upfront detection of male specific DNA while allowing for
subsequent sperm detection and or male DNA profiling. By performing a rapid mRNA
extraction, the detection of sperm could be determined relatively quick using HRM analysis and
by saving the extraction waste, the analyst could screen the sample for male DNA and use the
recovered DNA for male DNA profiling without having to perform additional extractions.
Current work is underway for a semen and sperm duplex RT-HRM assay that would allow for
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the detection of male DNA in low-level sperm samples or in the absence of sperm, as is the case
for vasectomized males.
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CHAPTER TWO: METHODOLOGY

Body Fluid Sample Preparation
All body fluids were collected from anonymous volunteers using procedures approved by
the University of Central Florida’s Institutional Review Board and informed consent was
obtained from each donor. All dried 50 µL blood stains (10 mL, Bioreclamation, Westbury, NY),
unless otherwise stated, were deposited onto sterile cotton swatches from a vacutainer containing
EDTA, dried at room temperature and stored at -46˚C until needed. Freshly ejaculated semen
was collected (10 donors; 3 mL, BIOIVT, Nassau, NY) (2 donors; 3 mL, Lee Biosolutions,
Maryland Heights, MO) in 15 mL conical tubes and stored at -20˚C. Once thawed, 50µL of
liquid semen was pipetted onto sterile cotton swabs or sterile cotton swabs were soaked directly
in the liquid. Mixture samples used in the Rapid Male DNA Screening Assay were made by
depositing 10, 5, 2 and 1 µL of liquid semen onto a tip-sized dried vaginal secretion swab. All
mixture samples were dried at room temperature overnight and stored at -20˚C until needed.
Buccal swabs (saliva) were collected by swabbing the inside of the donor’s mouth. Semen free
vaginal secretions and menstrual blood were collected using sterile cotton swab, dried overnight
at room temperature and stored at -20˚C until needed. All other stains used in RNA/DNA coextractions were made by pipetting 25, 10, 5, and 1 µL of un-preserved blood collected directly
from finger-pricks, freshly ejaculated semen, and liquid saliva, were pipetted onto sterile cotton
swatches, dried overnight at room temperature and stored at -20˚C until needed.
All mock casework stains and swabs used in RNA/DNA co-extractions were previously
prepared and stored at -46˚C until needed. Fifty microliters of liquid semen, saliva and blood
11

were deposited onto denim, polyester and paper swatches and incubated at room temperature for
1 week, 6 months and 1 year. Fifty microliters of liquid semen, saliva, and blood were deposited
on cotton swatches and incubated at 37˚C and 56˚C for 1 week to 1 month. Vaginal secretions
were collected on sterile cotton swabs and stored at room temperature, 37˚C, and 56˚C for 1
week and 1 month. Mixture samples were prepared by pipetting liquid body fluid (semen or
saliva) onto previously dried body fluid swabs dried at room temperature and stored at -20˚C
until needed.

PrepFiler™ Manual DNA Extraction
Total DNA was extracted from various semen, saliva, blood, menstrual blood, and
vaginal secretions using the PrepFiler Forensic DNA Extraction Kit (Applied Biosystems™ by
ThermoFisher, Foster City, CA) following the manufacturer’s recommended protocol [39]. Once
the PrepFiler™ lysis buffer and PrepFiler ™ Magnetic Particles were briefly incubated (10
minutes at 37˚C) to remove any precipitates, 300 µL of PrepFiler™ Lysis Buffer and 3 µL of 1
M DTT (5 µL for semen samples) were added to a PrepFiler™ spin tube containing the stain or
swab. The samples were incubated using a thermal shaker set at 70˚C and 900 rpm for 40
minutes to lyse the cells. The stain or swab was added to a PrepFiler™ filter column, placed back
into the original PrepFiler spin tube, and centrifuged at 14,000 rpm for two minutes. The filter
columns were discarded, and the tubes were incubated at room temperature for 5 minutes.
Next, 15 µL of magnetic beads, followed by 180 µL of isopropanol, was added to the
lysate and incubated (25˚C and 1,000 rpm for 10 minutes) to allow the DNA to bind to the beads.
Then the tubes were placed onto the PrepFiler™ magnetic stand (See Figure 1 to ensure proper
12

magnetic strip alignment) until the beads formed a pellet against the back of the tube or after
approximately 2 minutes for opaque liquids. The lysate remaining in the tubes (about 500 µL)
was removed and saved in a new 2 mL tube as “waste fraction 1.” The beads were washed three
times, 1) 600 µL of wash buffer A, 2) 300 µL of wash buffer A and, 3) 300 µL of wash buffer B
and collected as individual waste fraction or as a combined waste fraction. All waste fractions
were stored at -20˚C until purified. After the beads were allowed to air-dry with the tube cap
open for 7-10 minutes, 50 µL of elution buffer was added to the tubes and incubated (70˚C and
900 rpm for 5 minutes) to elute the DNA off of the beads. DNA extracts were used right away or
stored at 5˚C.

Figure 1 Illustration depicting the proper usage of the PrepFiler magnetic stand
[https://www.thermofisher.com/order/catalog/product/4463351.] [39]
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RNA Purification of PrepFiler™ DNA Waste Fractions
All individual and combined “waste fractions” were purified using the PureLink® RNA
Mini Kit (InvitrogenTM by ThermoFisher) and thawed, prior to purification. A PureLink® Lysis
buffer and ß-mercaptoethanol (Calbiochem® by Millipore Sigma, St. Louis, MO) mixture was
made based on the total volume of waste being purified (Table 1). An equal amount of lysis
buffer to waste volume was combined with 1 µL of ß-mercaptoethanol per 100 µL of lysis buffer
and added to the waste fractions. Then, an equal volume of 100% ethanol was added to the waste
and the entire volume of lysate was flowed through a PureLink® filter cartridge (centrifuged for
15 sec. at 14,000 rpm). With each flow through, the collection tube was discarded, and the
cartridge was placed in a new collection tube. Table 1 and Table 2 list the number of flowthrough steps necessary for each volume of waste. Next, the membrane was washed three times
with 1) 650 µL of wash buffer I and, 2) 500 µL of wash buffer II twice (centrifuging for 15 sec.
at 14,000 rpm) replacing the collection tube each time. The membrane filter cartridge was dried
by centrifuging at 12,000 x g for 1 minute and placed in a new 1.5 mL recovery tube. Finally, 30
µL of RNase-free water was added to the center of the membrane and centrifuged at 12,000 x g
for 2 min to elute the purified RNA off of the membrane.
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Table 1 The contents, total volume and number of purification flow through steps required
for Waste Fractions 1 through 4
Number of Flow
Waste Fraction
Contents
Total Volume
Through Steps
Lysis Buffer, DTT,
1
500 µL
3
Isopropanol
Wash Buffer A
2
600 µL
3
(mostly ethanol)
Wash Buffer A
3
300 µL
2
(mostly ethanol)
Wash Buffer B
4
300 µL
2
(mostly ethanol)
Table 2 Flow through steps needed when all of the waste fractions are combined together
Volume of
Number of Flow
Waste (µL)
Through Steps
200
1
300
2
500
3
600
3
650
3
750
4
1,000
5
1500
7
RNA Extraction for Rapid Male DNA Identification Assay
All single sourced and mixture samples were extracted using the Dynabeads™ mRNA
Direct™ Purification kit (Invitrogen™ by Thermo Fisher). All reagents were stored at 5˚C and
the Lysis/Binding buffer, Dynabeads™ oligo (dT)25 and Washing Buffer A and B were brought
to room temperature prior to use to remove any precipitates in the solutions. A small piece of
sample (Figure 2) and 100 µL of Lysis/Binding Buffer were added to a sterile 1.5 mL tube and
incubated at 70˚C and 750 rpm for 10 minutes. The swab was added to a spin basket, centrifuged
at 1300 rpm for 3 minutes then discarded. Next, 10 µL of Dynabeads™ oligo (dT)25 were added
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to the lysate and incubated at room temperature for 5 min. The samples were added to a
DynaMag-2™ magnet and once a pellet formed against the tube walls, or after about two
minutes for opaque liquids, the lysate was removed and saved for further DNA analysis. The
beads were washed three times with 1) 600 µL of Wash Buffer A twice, then 2) 300 µL of Wash
Buffer B. Finally, 10 µL of 10 mM Tris-HCl (elution buffer) was washed across the beads,
incubated at 65˚C and 350 rpm for 2 min, and removed for further RNA analysis.

Figure 2 Image of the sample size used in the mRNA Direct RNA extraction
DNase Treatment of All RNA Extracts
All RNA extracts were DNase-treated using the TURBO™ Dnase kit (Invitrogen™ by
ThermoFisher) to remove DNA remaining in the sample. 1 µL of TURBO DNase™ Buffer (per
1 µL of extract) and 1 µL of Turbo DNase™ was added to the samples. Samples were incubated
at 37˚C for 30 minutes and then 75˚C for 10 minutes. All DNase-treated RNA extracts were
stored at -20˚C until further analysis was performed.
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cDNA Synthesis of Purified Waste and DNA From RNA Aliquots
All DNase-treated RNA extracts were reverse transcribed using the SuperScript™ IV
(SS4) Vilo™ Master Mix kit (Invitrogen™ by Thermo Fisher). A 20 µL reaction mix containing
4 µL of SS4™ Vilo™ Master Mix, 8 µL of nuclease-free water and 8 µL of sample was added to
0.2 µL MicroAmp™ tubes (Applied Biosystems™ by ThermoFisher). Samples were reversetranscribed using the following cycling program: one cycle at 25˚C, 10 min; 50˚C, 10 min; 85˚C
5 min using a GeneAmp® PCR System 9700 (Applied Biosystems™ by ThermoFisher). All RT
products were stored at -20˚C until needed.

cDNA Amplification of Purified Waste and RNA From DNA Aliquots
All cDNA samples were amplified using the AmpliTaq™ Gold 360 Master Mix Kit
(Applied Biosystems™ by ThermoFisher). An 11.5 µL reaction mix containing 6.25 µL of
AmpliTaq™ Gold® 360 Master Mix, 1.25 µL of 360 GC Enhancer, 1.25 µL of an in-house CE
10-plex primer mix Table 3), 2.75 µL of RNase-free water and 1 µL of reverse transcribed
cDNA was added to 0.2 µL MicroAmp™ tubes (Applied Biosystems™ by ThermoFisher). The
following PCR program was performed using a GeneAmp® PCR System 9700 (Applied
Biosystems™ by ThermoFisher): 95˚C, 15 min; followed by 33 cycles at 94˚C, 30 sec; 55˚C, 90
sec (+0.2˚C/cycle); 72˚C, 45 sec and ending at 72˚C, 30 min.
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Table 3 10-Plex body fluid marker Primer Mix prepared in-house for Multi-plex PCR
Volume
Concentration
Product
added to
Marker
Body Fluid ID
Primer
(pmol/µL)
Size (bp)
Primer Mix
(µL)
200
ANK1 [29]
Blood
113
R2, FF
5
100
ALAS2 [27, 28]
Blood
134
R, FF
0.45
100
PRM2 [26-28]
Sperm
91
R2, F2V
0.25
100
SEMG1 [28, 29]
Semen
86
R3, FN
0.3
200
HTN3 [26-28]
Saliva
227
R, FN
4.5
200
STATH [26-28]
Saliva
181
R, FN
6.0
Vaginal
100
CYP2B7P1 [24]
198
R, FF
1.5
Secretions
Menstrual
100
MMP10 [27-29]
168
R, F2F
0.75
Blood
Menstrual
100
LEFTY2 [28]
126
R, FP
4
Blood
100
LCE1C [23]
Skin
60/62
R2, FP
0.3
H2 O
53.9
Capillary Electrophoresis and Data Analysis
of cDNA From Purified Waste and DNA From RNA Aliquots
Capillary electrophoresis was performed using an ABI 3130 Genetic Analyzer (Applied
Biosystems™ by ThermoFisher). An 11.5 µL reaction mix containing 9.7 µL Hi-Di™
formamide (Applied Biosystems™ by ThermoFisher), 0.3 µL GeneScan™ 500 LIZ™ dye Size
Standard (Applied Biosystems™ by ThermoFIsher) and 1 µL of sample was added to a 96-well
plate and covered with a plate septa. Samples were injected through a 4-capillary 36 cm array
with POP-7™ polymer (Applied Biosystems™ by ThermoFisher), using run ModuleG5_General
and FragmentAnalysis36_POP7 template (18 sec injection, 1.2 kVolts, 60˚C, 1200 sec run time).
Samples were analyzed using 3130 Genetic Analyzer Data Collection Software v3.0 (Applied
Biosystems™ by ThermoFisher).
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High Resolution Melt (HRM) analysis for Rapid Male DNA Screening Assay
All RNA extracts were screened for the presence of sperm using the Power SYBR®
Green RNA-to-CT™ 1-Step Kit (Applied Biosystems™). An 18µL single-plex reaction mix
containing 10 µL of PowerSYBR® Green RT PCR mix, 2 µL of 10 µM PRM2 (sperm) forward
and reverse primers (primers were custom designed by Invitrogen, Table 4), 0.16 µL of 10X RT
enzyme mix, 3.84 µL of RNase-free water and 2 µL of DNased mRNA extract, was added to a
96-well plate. The plate was sealed using an Optical Adhesive Film and analyzed on a 7500
Real-Time PCR instrument (Applied Biosystems™) using the HID Real-Time PCR Analysis
Software. A modified reduced-time Power SYBR® run protocol was used: reverse transcription
(48˚C, 15 min), followed by a hot start to activate the Taq polymerase (95˚C, 10 min), 40 cycles
of PCR (95˚C, 15 sec; 60˚C, 30 sec), ending with the melt curve stage ( 95˚C, 15 sec; 60˚C, 15
sec; 95˚C, 15 sec).
Table 4 Primer Design for PRM2 forward and reverse primers used in 1-Step Reverse
Transcription-HRM single plex assay
Primer
Sequence (5’ to 3’)
Primer Length
PRM2-F-HRM

(DNA) GGC GCA AAA GAC GCT CC
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PRM2-R-HRM

(DNA) GCC CAG GAA GCT TAG TGC C
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DNA Quantification
All DNA extracts were quantified using the Quantifiler™ Trio DNA Quantification kit
(Applied Biosystems™ by ThermoFisher) according to the manufacture’s protocol. A set of
Quantifiler™ Trio DNA standards were prepared ranging from 0.005-50 ng/µL of DNA. A 20
µL reaction mix containing 8 µL of Quantifiler™ Trio Primer mix, 10 µL of Quantifiler™ Trio
Reaction mix and 2 µL of sample or standard was dispensed into designated wells of a 96-well
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plate. The plate was sealed using a MicroAmp™ Optical Adhesive Film (Applied Biosystems™
by ThermoFisher) and analyzed in real-time using the HID Real-Time PCR Analysis Software
v1.2 on a 7500 Real-Time PCR instrument (Applied Biosystems™ by ThermoFisher). Total
human and male DNA was quantified with respect to the small autosomal (QSY7 target and
NFQ-MGB quencher) and T.Y. target (FAM target, NFQ-MGB quencher). The samples were
amplified using the following program: 95˚C hot start for 2 minutes followed by 40 cycles of
95˚C 9 sec; 60˚C 30 sec. The total amount of human and male DNA in each sample was
analyzed in ng/µL with respect to a standard DNA curve (R value > 0.99). All DNA samples
were diluted to a target DNA concentration of 0.5 ng/µL, if necessary, using DNA Suspension
Buffer (Tris 10 mM, EDTA 0.1 mM, pH 8.0) (TEKnova, Hollister, CA).

DNA Amplification
All DNA extracts extracted using the PrepFiler™ Forensic DNA Extraction Kit were
amplified using the GlobalFiler™ PCR Amplification Kit (Applied Biosystems™ by
ThermoFisher) according to the manufactures standard protocol. The 6-dye, short tandem repeat
(STR) multiplex assay kit amplifies human genomic DNA at a target DNA concentration of 0.5
ng/µL allowing for the detection of 21 autosomal STR loci, 1 Y-STR, 1 insertion/deletion
polymorphic marker on the Y chromosome, and Amelogenin (sex determining marker) [44]. An
11.5 µL total reaction mix containing 3.75 µL of GlobalFiler™ Reagent mix, 1.25 µL of
GlobalFiler™ Primer mix, 6.5 µL of DNA Suspension Buffer (TEKnova), and 1 µL 0.5 ng/µL
DNA extract was added to 0.2 µL MicroAmp™ tubes (Applied Biosystems™ by ThermoFisher).
All samples were amplified using the GeneAmp® PCR System 9700 (Applied Biosystems™ by
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ThermoFisher) under the following program: 95˚C, 1 min in max ramp mode; 29 cycles 94˚C, 10
sec; 59˚C, 90 sec; 60˚C, 10 min.
DNA waste fractions saved from the mRNA Direct™ RNA extraction were amplified
with the Yfiler™ Plus PCR Amplification Kit (Applied Biosystems™) according to the
manufacture’s reduced volume protocol [45]. All DNA extracts were diluted to a Y-target
concentration of 0.5 ng/µL prior to amplification. An 11.5 µL reaction mix containing 5 µL of
Yfiler™ Plus master mix, 2.5 µL of Yfiler™ Plus Primer mix, 4 µL of DNA suspension buffer
and 1 µL of 0.5 ng/µL DNA extract was added to 0.2 µL MicroAmp™ tubes. All samples were
amplified using a 9700 Applied Biosystems™ Thermal Cycler under the following program: hot
start to activate the Taq polymerase (95˚C, 1 min), followed by 30 cycles of denaturing and
annealing (94˚C, 5 sec; 61.5˚C, 1 min), ending with a final extension (60˚C, 22 min).

Capillary Electrophoresis and Data Analysis
Electrophoresis was performed on all amplified DNA products to separate the DNA
fragments by size and color using a 6-dye fluorescent system. Each dye correlated to a single
color (6-FAM, blue; VIC, green; NED, yellow; TAZ, red; SID, purple; LIZ, orange), excited by
a laser and detected as a relative fluorescent unit. Electrophoresis was performed using an ABI
3130 Genetic Analyzer (Applied Biosystems™ by ThermoFisher) and the fluorescence data was
captured using the 3130 Genetic Analyzer Data Collection Software v3.0 (Applied Biosystems™
by ThermoFisher). For all DNA products amplified with the GlobalFiler™ PCR Amplification
Kit (Applied Biosystems™ by ThermoFisher), an 11 µL total reaction volume containing 9.6 µL
Hi-Di formamide (Applied Biosystems™ by ThermoFisher), 0.4 µL GeneScan™ 600 LIZ™ dye
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Size Standard v2.0 (Applied Biosystems™ by ThermoFisher) and 1 µL of sample or
GlobalFiler™ Allelic Ladder (Applied Biosystems™ by ThermoFisher) was added to a 96-well
plate and covered with a plate septa. Samples were injected through a 4-capillary 36 cm array
with both POP-7™ or POP-4™ polymer (Applied Biosystems™ by ThermoFisher), under the
run module GlobalFiler_10sec.inj or J6_POP4_GF3 and the FragmentAnalysis36_POP7 (10 sec
injection, 1.2 kVolts, 60˚C, 1500 sec run time) or HIDFragmentAnalysis36_POP4 template (2
sec injection, 1.5 kVolts, 60˚C, 1500 sec run time). Samples amplified using the Yfiler™ Plus
PCR amplification kit were plated as previously described with the exception of a Yfiler™ Plus
Allelic Ladder. All samples amplified using the Yfiler ™ Plus Amplification kit were
electrophoresed using the following 3130xl protocol: Injected through a 4-capillary 36 cm array
with POP-4™ polymer, run module J6_POP4_General and HIDFragmentAnalysis36_POP4
template (5 sec injection, 3 kVolts, 60˚C, 1500 sec run time). All signals were detected by the
3130 Genetic Analyzer Data Collection Software v3.0 and analyzed using the GeneMapper™
ID-X software as individual electropherograms.
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CHAPTER THREE: RESULTS
INTEGRATION OF MRNA PROFILING INTO AN ESTALISHED DNA
WORKFLOW

To evaluate the capability of recovering RNA from an established DNA extraction, a
number of initial validation studies were performed. First, the DNA extraction waste fractions
were saved and purified to removed impurities such as PCR inhibitors and extraneous DNA. All
purified waste was analyzed using multiplex-PCR followed by CE that had the ability to detect,
via specific mRNA biomarkers, the presence of saliva, semen, blood, vaginal secretions
menstrual blood and skin (not specifically studied). All of these body fluid types are routinely
encountered in biological evidence and are potential sources of DNA. The PrepFiler™ DNA
extraction involves multiple wash steps, each being potential sources for RNA recovery. An
initial waste fraction validation was performed to locate the best chances for RNA recovery by
analyzing the successful detection of multiple single sourced body fluid samples. Next, a sample
size validation study was performed to determine the success rate of detecting body fluids when
increasingly smaller amounts of body fluid are present. To determine if RNA could be recovered
by other means, the DNA extract itself was analyzed with respect to its ability to successfully
detect body fluids. Upon successful detection of all body fluids without the need for purification,
an initial analysis of different extract volumes was performed and allowed for a direct
comparison between the two methods. Finally, mock casework samples were analyzed to ensure
both methods were capable of detecting body fluids exposed to forensically relevant
circumstances.
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Initial Waste Fraction Validation
To determine if RNA recovery was possible without modifying the PrepFiler™ DNA
extraction, the saved waste fractions were purified both individually and combined. To analyze
the all relevant body fluids using PCR, a 10-plex primer mix containing markers for semen
[PRM2 and SEMG1], blood [ANK1 and ALAS2], vaginal secretions [CYP2B7P1], saliva
[STATH and HTN3] and menstrual blood [MMP10 and LEFTY2]) and skin (LCE1C) (Table 1)
was used. Figure 3 represents a positive detection of all corresponding body fluids if they were
present in a mixture. Only body fluid markers observed above the 50 RFU threshold were
considered to be detected. To initially test the extraction waste fractions, two sets of single
sourced saliva, blood, semen, vaginal secretions, and menstrual blood samples were analyzed in
regard to their corresponding body fluid markers. Upon initial testing it was observed that whole
blood and semen swabs/stains overwhelmed the beads during the extraction process, causing
beads to be pulled into the saved waste fractions. Therefore, all initial waste fraction testing was
performed using ½ of a 50 µL blood stain and ½ or ¼ of a swab for all other body fluids. First,
individual waste fractions were analyzed separately to 1) determine if RNA could be recovered
in the waste of the extraction and 2) determine which waste fraction was consistently able to
detect the correct body fluid markers for each sample. Table 5 summarizes the total number of
body fluid specific markers detected for each corresponding body fluid in each waste fraction
after purification. Body fluids were detected in all of the waste fractions. However, waste
fraction 1 successfully detected all of the body fluid markers when ½ stains and swabs were
tested. Similar levels of detection were observed for waste fraction 1 when ¼ sized swabs were
tested for more proteinaceous body fluids (vaginal secretions and semen).
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Figure 3 Electropherogram of all possible body fluid markers detected using an in-house
CE 10-plex primer mix.
Blue channel (FAM) - ANK1 and ALAS2 - blood markers, MMP10 – menstrual blood,
CYP2B7P1 – vaginal secretions. Green channel (VIC) - PRM2 – sperm marker. Yellow channel
(NED, shown in black) - SEMG1 – seminal fluid, STATH and HTN3 - saliva. Red channel
(PET) - LEFTY2 – menstrual blood. Below each peak is the name, the RFU value and the base
pair size of the detected gene product. X-axis: base pair (bp) size; Y-axis: relative fluorescence
units (RFUs).
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Table 5 Detection of saliva, vaginal secretions, semen, menstrual blood, and blood mRNA
body fluid markers in individual extraction waste fractions after purification.
The detection of a body fluid marker is indicated by a colored cell (saliva-blue, vaginal
secretions- green, semen-yellow, menstrual blood-pink, blood-red). The cell is colored gray
when no corresponding body fluid markers were detected for the total number of samples tested.
The total number of markers detected in each sample out of the total number of samples tested
are listed in each cell. a) contains the results for ½ sized stains or swabs; b) table contains the
results from ¼ sized swabs.

a)

b)

Body Fluid Detection in Individual Extraction Waste Fractions
Waste Fraction
Body Fluid
Marker Swab Size
1
2
3
4
Vaginal
CYP2B7P1
1/2
1/2
0/2
1/2
1/4
PRM2
2/2
2/2
1/2
1/2
Semen
SEMG1
2/2
0/2
0/2
0/2

Next, the waste fractions were combined to determine 1) if RNA recovery was still
possible when aliquots of waste were purified and 2) to determine if RNA recovery is more or
less successful when compared to separate waste fractions. Two sets of each body fluid for each
aliquot size were analyzed with the exception of the ¼ sized semen swabs (four sets of donors
for the 1500 µL and 750 µL aliquots). Aliquots of 1500 µL, 1000 µL, 750 µL and 500 µL were
purified and the results can be seen in Table 6. The 1500 µL and 1000 µL aliquots were able to
identify all single sourced body fluids similar to waste fraction 1.
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Table 6 Detection of saliva, vaginal secretions, semen, menstrual blood, and blood mRNA
body fluid markers in aliquots of combined waste fractions after purification.
The detection of a body fluid marker is indicated by a colored cell (saliva-blue, vaginal
secretions- green, semen-yellow, menstrual blood-pink, blood-red). The cell is colored gray
when no corresponding body fluid markers were detected for the total number of samples tested.
The total number of markers detected in each sample out of the total number of samples tested
are listed in each cell. a) contains the results for ½ sized stains or swabs, and b) contains the
results from ¼ sized swabs.

a)

b)
However, to achieve similar results as waste fraction 1, the number of flow through steps were
increased, causing an increase in resources and time. As the volume of waste used was
decreased, the success rate for body fluid identification also decreased. The 500 µL aliquot, the
same volume of waste purified for waste fraction 1 separately, did not allow for consistent body
fluid identification of saliva, vaginal, menstrual blood or blood samples. This is not unexpected
as the combined waste contains essentially diluted waste since not as much RNA is recovered
from subsequent waste fractions. Although RNA recovery is achievable when the waste fractions
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were combined, body fluid identification was more consistently successful when waste fraction 1
was purified separately. Therefore, all further validation studies included analysis of waste
fraction 1 only.

Initial Sample Size Validation
To determine the optimal sample size that would allow for all forensically relevant body
fluids to be successfully identified, the following sample sizes were tested: 1) dried saliva,
vaginal, semen, menstrual blood swabs - ½ , ¼ and 1/8 swabs; 2) dried 50 µL blood, semen and
saliva stains - ½, ¼, and 1/8 stains; and 3) whole 25, 10, 5, and 1 µL blood, semen and saliva
stains were analyzed. Each sample/swab size for each body fluid were analyzed with two
different donors with the exception of liquid saliva and semen stains (4 different saliva donors
and 3 different semen donors). These sample types were more challenging, and evaluation of
additional donors was necessary. The results can be seen in Table 7 and lists all of the body fluid
makers that were detected for each sample size. A positive identification of all ½ sized saliva,
vaginal secretions, semen, and menstrual blood swabs and blood stains were observed, which is
consistent with the results from the initial waste fraction validation study. Additionally, semen
and vaginal secretions were correctly identified for all swab sizes that were tested. Liquid semen
and saliva stains were more variable, being identified in only 50 and 33 percent of the ½ and ¼
50 µL stains, respectively. Additional donors were tested to ensure the variable detection was
genuine and not due to possible sample issues. Un-preserved blood, semen and saliva were
available in liquid form for variable stain size testing. Blood was the only body fluid detectable
when 25 µL of liquid was deposited as a stain.
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Table 7 Detection of saliva, vaginal secretions, semen, menstrual blood, and blood mRNA
body fluid markers in various sample sizes.
The detection of a body fluid marker is indicated by a colored cell (saliva-blue, vaginal
secretions-green, semen-yellow, menstrual blood-pink, blood-red). The cell is colored gray when
no corresponding body fluid markers were detected for the total number of samples tested. The
total number of markers detected in each sample out of the total number of samples tested are
listed in each cell. a) contains the results for all swab sizes and 50 µL stain sizes, b) contains the
results from specific volumes of liquid dried as a stain.

a)

b)
Unfortunately, saliva and semen were only detectable in one out of the total number of 25 µL
samples tested. Although all body fluids on swabs were able to be correctly identified, more
analysis needs to be performed to ensure mRNA profiling can be performed with liquid body
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fluid stains using this method. Based on these results, the optimal sample size for saliva, and
menstrual blood was determined to be ½ of a swab, ¼ of a semen and vaginal secretion swab,
and ½ of a 50 µL blood, saliva and semen stain. For this to be applied in casework, labs would
need to evaluate their own standard sample size because the body fluid of origin would be
unknown, and the sample size would typically be consistent amongst all evidence being
processed. For the purpose of this study, further validation studies included an analysis of the
sample sizes with respect to each body fluid type previously mentioned and any other sample
sizes not included would need to be assessed.

RNA from DNA
Although RNA was successfully recovered and analyzed using purified DNA-extraction
waste, it was not successful for all samples. A possible explanation for some of these differences
was that some of the RNA may be retained on the silica-based magnetic beads and therefore
eluted into the DNA extract itself rather than being present in the waste fractions as originally
expected. Therefore, DNA extracts were evaluated in order to determine if RNA was present and
could be used without the need for additional purification as was performed with waste fraction
testing. Without modifications to the DNA workflow, an aliquot of the 50 µL DNA extract (48
µL after DNA quantification and 33 µL after amplification) was DNase treated, amplified using
the original 10-plex primer mix and electrophoresed, consistent with the purified waste fractions.
Initial testing was performed using 25 µL (half the total elution volume) of saliva samples
previously extracted from the sample size validation study. As can be seen in Table 8, saliva
body fluid markers were detected for some samples that were previously undetectable using the
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Table 8 Comparison of body fluid markers detected in saliva, vaginal secretions, semen,
menstrual blood, and blood samples when extraction waste fractions are purified vs. when
aliquots of un-purified DNA extracts are analyzed.
The detection of a body fluid marker is indicated by a colored cell (saliva-blue, vaginal
secretions- green, semen-yellow, menstrual blood-pink, blood-red). The cell is colored gray
when no corresponding body fluid markers were detected for the total number of samples tested.
The total number of markers detected in each sample out of the total number of samples tested
are listed in each cell. a) contains the results for all ½ swab and ½ 50 µL stain sizes, b) contains
the results from specific volumes of liquid dried as a stain. RFD = RNA recovered from DNA
extracts

31

purified method. Specifically, the saliva body fluid markers, HTN3 and STATH, were not
detected in purified waste fraction 1 for the 5 µL and 1 µL saliva stains. The RNA from DNA
method (referred to as RFD subsequently) was able to detect 50-75% more saliva markers in
these samples when compared with the purification method. Although preliminary testing was
performed using 25 µL of DNA extract, it was determined that that volume may not be realistic
for operational laboratories to use since they would need to retain some extract for additional
testing. As a result, the volume of DNA extract was lowered to 10 µL for testing of the
previously extracted size variable samples. Again, Table 8 compares the number of body fluid
markers detected when the purified method and the RNA from DNA method was used with only
10 µL of DNA extract. When both methods were compared, the 10 µL RFD volume, in all cases
except two, resulted in the detection the same or increased numbers of body fluid markers.
PRM2 in one semen sample and ALAS2 in one blood sample were undetected with the RFD
method while previously detected using the waste purification method. In order to ensure that
these negative results were not due to the reduced volume, all further validation studies were
performed using 15 µL of DNA extract for the RFD method.

Mock Casework Validation
Although the results indicate that the developed co-extraction method can successfully
recover RNA from single sourced body fluid samples, it was important to determine if the same
results would be obtained from casework-type samples that are not always found in ideal
conditions. To determine if this method was suitable for use with mock casework samples,
studies were performed using body fluids deposited onto different substrates, exposed to varying
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environmental temperatures and two-fluid admixed body fluid samples. Fifty microliters of
liquid saliva, semen and blood were deposited on forensically relevant textiles (denim, polyester
and paper) and incubated at room temperature for 1 month, 6 months, and 1 year. Next, the same
body fluids were deposited onto cotton swatches and exposed to harsh temperatures (37˚C and
56˚C) for 1 week and 1 month. Vaginal swabs exposed to room temperature, 37˚C and 56˚C for
1 week and 1 month were also analyzed. Finally, to test the methods success rate for detecting
two body fluids simultaneously, two-person mixtures were analyzed that contained various
amounts of liquid semen or saliva deposited onto dried body fluid stains or swabs. All samples
were extracted using two different donors if possible and the results are summarized in Table 9.
When body fluids were deposited on denim, there was not enough RNA recovered in the waste
fraction to successfully identify semen or saliva under any time point, which can be seen in
Table 9a. Although blood was detectable, it was not identified in half of the samples tested. In
comparison, the RFD method was able to provide some additional marker detection. ANK1
markers were detectable on all 6-month blood on denim samples but was unable to detect a
single marker in the 1-year denim samples, previously detectable using the purified waste. The
lack of detection with these samples could be due to fibers, invisible to the naked eye, remaining
in the lysate. Although, most fibers were removed using a waste basket, some fibers remained
and bound to the magnetic beads making the beads unable to stick to the walls of the tube. This
effected the amount of DNA as well as RNA recovered. This sample problem was not observed
with paper or polyester. Interestingly, blood and saliva were detected more often in the DNA
extract than in the waste fraction when the body fluids were deposited on paper and polyester.
Semen was detectable, in almost every case for both methods and was the most successfully
detected body fluid amongst the three tested on polyester and paper.
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Table 9 Comparison of body fluid markers detected in mock casework samples using purified extraction waste fractions and
15 µL of DNA extract.
The detection of a body fluid markers is indicated by a colored cell (saliva-blue, vaginal secretions- green, semen-yellow, menstrual
blood-pink, blood-red). The cell is colored gray when no corresponding body fluid markers were detected for the total number of
samples tested. The total number of markers detected in each sample out of the total number of samples tested are listed in each cell.
(a) shows the results for body fluids deposited on denim, polyester and paper, over time and compares detection when the purified
waste and RFD methods were used. (b) shows the results for body fluids deposited on cotton swatches or from swabs that were
exposed to increased temperatures over time and compares detection when the purified waste and RFD methods were used.

a)

b)
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A similar trend was observed for saliva samples exposed to increased temperatures over
time (Table 9b). Saliva was not identified in any of the samples tested. However, unlike with the
substrate samples, blood was detected in all of the samples exposed at 56˚C and all samples
except a 1-week sample exposed at 37˚C when the waste was tested. Semen was less variable
and was able to be detected in all temperatures over time using the RFD method as well as the
purified waste method with the exception of one sample exposed to 56˚C for 1 week.
Additionally, half of the vaginal samples across all temperatures over time were successfully
identified using the RFD method, whereas one 37˚C 1-week and one 56˚C 1-week vaginal
sample was detected using the purified waste method. Because blood and semen could be
identified in most all cases, it can be said that both body fluids can be successfully identified
using both methods when exposed to extreme temperatures over time. Although both RNA and
DNA are expected to be highly degraded for these sample types, body fluid identification and
autosomal STR typing were not negatively effected overall.
Finally, to determine if this method was able to positively identify two different body
fluids simultaneously, liquid semen and saliva was deposited in various amounts on different
dried body fluid swabs. The results of the mixture analysis can be seen in Table 10 and compares
the two RNA recovery methods. When semen was deposited onto dried vaginal secretions,
semen was detected in half of the tested samples in as little as 1 µL of liquid body using the
purified waste method. Vaginal secretions were not detected in these samples when either
method is used. Body fluid detection was more successful for the other mixtures when liquid
semen was deposited on dried blood, saliva and menstrual blood swabs.
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Table 10 Comparison of body fluid markers detected in two-body fluid mixtures when
extraction waste fractions are purified and when 15 µL of DNA extract is used.
The detection of a body fluid markers is indicated by a colored cell (saliva-blue, vaginal
secretions- green, semen-yellow, menstrual blood-pink, blood-red). The cell is colored gray
when no corresponding body fluid markers were detected for the total number of samples tested.
The total number of markers detected in each sample out of the total number of samples tested
are listed in each cell a) shows the results for the mixtures where liquid semen was deposited
onto a different dried body fluid swab and compares both RNA recovery methods; b) shows the
results for the mixtures where liquid saliva was deposited onto a different dried body fluid swab
and compares both RNA recovery methods
Dried Body Fluid

Vaginal- Semen

Blood- Semen

Saliva-Semen

Menstrual BloodSemen

a)
Dried Body Fluid

Vaginal- Saliva

Blood- Saliva

Menstrual BloodSaliva

b)

Volume of
liquid Body
Fluid (µL)

Body Fluid 1
Purified

Body Fluid 2
RFD

Marker
10
5
1
Marker
10
5
1
Marker
10
5
1
Marker
10
5
1

CYP2B7P1
CYP2B7P1
0/2
0/2
0/2
0/2
0/2
0/2
ANK1 ALAS2 ANK1 ALAS2
2/2
1/2
0/2
0/2
1/2
0/2
0/2
0/2
0/2
0/2
1/2
0/2
STATH HNT3 STATH HNT3
0/2
1/2
0/2
0/2
1/2
1/2
0/2
0/2
2/2
0/2
0/2
0/2
MMP10 LEFTY2 MMP10 LEFTY2
1/2
0/2
1/2
0/2
1/2
1/2
0/2
0/2
1/2
1/2
1/2
1/2

Volume of
liquid Body
Fluid (µL)

Body Fluid 1

Marker
10
5
1
Marker
10
5
1
Marker
10
5
1

Purified

Purified
PRM2
1/2
1/2
1/2
PRM2
1/2
1/2
0/2
PRM2
1/2
1/2
1/2
PRM2
2/2
2/2
1/2

PRM2
0/2
0/2
1/2
PRM2
0/2
1/2
1/2
PRM2
0/2
1/2
1/2
PRM2
1/2
0/2
2/2

SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2

Body Fluid 2
RFD

Purified

CYP2B7P1
CYP2B7P1
STATH
1/2
1/2
1/2
1/2
1/2
0/2
1/2
1/2
0/2
ANK1 ALAS2 ANK1 ALAS2 STATH
2/2
1/2
2/2
1/2
2/2
1/2
1/2
1/2
0/2
1/2
2/2
1/2
2/2
1/2
1/2
MMP10 LEFTY2 MMP10 LEFTY2 STATH
1/2
0/2
1/2
0/2
0/2
1/2
1/2
1/2
1/2
0/2
1/2
1/2
2/2
1/2
0/2
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SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2
SEMG1
0/2
0/2
0/2

RFD

RFD

HNT3 STATH HNT3
1/2
1/2
1/2
0/2
0/2
0/2
0/2
0/2
0/2
HNT3 STATH HNT3
2/2
2/2
2/2
2/2
0/2
0/2
0/2
1/2
1/2
HNT3 STATH HNT3
0/2
1/2
1/2
0/2
1/2
1/2
0/2
0/2
0/2

In some cases, both body fluids were identified, and semen especially was identified in at least
half of all samples tested. Next, when liquid saliva was deposited onto various dried body fluid
swabs, both body fluids (except in the case of the 5 µL and 1 µL vaginal-saliva samples) were
able to be detected when both RNA recovery methods were taken into account. Dried blood and
liquid saliva mixtures were the most consistently successful samples allowing for a positive
identification of both body fluids with as little as 1 µL of saliva. In most cases, a successful
identification of both body fluids was possible in one of the two donor sets tested for a particular
variable. Unfortunately, RNA recovery for both methods was too variable to conclude whether
mRNA profiling can successfully identify two-body fluid mixtures when liquid semen or saliva
are deposited onto various dried swabs.

DNA Analysis
All samples were extracted, quantified, amplified and electrophoresed to ensure the DNA
workflow was not affected by integrating mRNA profiling into the workflow. As can be seen in
Table 11 a total number of 294 biological samples were extracted and amongst them, an average
of 3,705 ng of DNA was recovered, allowing for complete STR detection in all preliminary
validation studies. Likewise, when as little as 1 µL of liquid body fluid or 1/8 of a 50 µL stain
(Figure 4 and Figure 5) was extracted using the co-extraction method, complete profiles were
obtained. Although DNA recovery was consistently reliable for these types of samples, problems
arose when body fluids were deposited on various substrates. When body fluids were deposited
onto denim, abnormally low-levels of DNA were recovered
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Table 11 The number of biological samples and their average DNA recovery using the
PrepFiler™ DNA Extraction Kit for validation of RNA recovery in purified extraction
waste and aliquots of DNA extract
Validation
# of Samples
Avg. DNA Conc.
Avg. Total DNA
Variable
Study
Extracted
(ng/µL)
(ng)
Separate Waste
14
154.0
7700
Waste
Combined
Fraction
63
104.3
5215
Waste
Sample
Swabs/Stains
86
48.8
2440
Size
Substrate
53
6.0
300
Deposition
Mock
Temperature
Casework
36
81.0
4050
Exposure
Mixtures
42
50.5
2525
Total

294

74.1

3705

(average of 52 ng total yield of DNA) due not only to invisible fibers left in the lysate but also
due to extraction inhibition caused by the indigo dyes in denim. Once the PrepFiler™ magnetic
particles were added, they adhered to the fibers causing the beads to accumulate at the bottom of
the tube, making lysate removal difficult. Although problems with the extraction were
encountered, full profiles were obtained for all samples that contained fibers. As can be seen in
Figure 6, even though 2 ng total yield of DNA was obtained (0.3 ng input into amp when the
recommended input is 0.5 ng) from a semen sample deposited on denim and exposed to room
temperature for 1 year, a complete STR profile was still obtained. It should be noted that the
alleles at CSF1PO, D7S280 and SE33 locus have observably low RFU signals but are still above
the 50 RFU threshold. This reduction in peak heights for some of the larger loci (i.e. ski slope
effect) may be due to the fact that this was a low template sample. Full profiles were obtained for
all other samples that were deposited on paper or polyester.
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Figure 4 Autosomal STR profile from a 1 µL female saliva stain.
Complete 24 loci GlobalFiler™ profile of DNA recovered from a 1 µL saliva stain using a
PrepFiler™ manual DNA extraction. Loci separated by dye color: Blue Channel (6-FAM),
Green Channel (VIC), Yellow Channel (NED - shown in black), Red Channel (TAZ), Purple
Channel (SID) purple; Channel Orange (LIZ-not shown). Below each peak is the allele call, and
the RFU value. X-axis: base pair (bp) size; Y-axis: relative fluorescence units (RFUs).
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Figure 5 Autosomal STR profile of a 1/8th sized portion of a female 50 µL saliva stain.
Complete 24 loci GlobalFiler™ profile of DNA recovered from a 1/8 sized portion of a 50 µL
saliva stain using a PrepFiler™ manual DNA extraction. Loci separated by dye color: Blue
Channel (6-FAM), Green Channel (VIC), Yellow Channel (NED - shown in black), Red Channel
(TAZ), Purple Channel (SID) purple; Channel Orange (LIZ-not shown). Below each peak is the
allele call, and the RFU value. X-axis: base pair (bp) size; Y-axis: relative fluorescence units
(RFUs).
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Figure 6 Autosomal STR profile of a semen stain deposited on denim and incubated at
room temperature for one year.
Complete 24 loci GlobalFiler™ profile of DNA recovered from a semen stain deposited on
denim and incubated at room temperature for one year using a PrepFiler™ manual DNA
extraction. A max input of 0.3 ng of DNA was input into the amp (0.5 ng recommended). Loci
separated by dye color: Blue Channel (6-FAM), Green Channel (VIC), Yellow Channel (NED shown in black), Red Channel (TAZ), Purple Channel (SID) purple; Channel Orange (LIZ-not
shown). Below each peak is the allele call, and the RFU value. X-axis: base pair (bp) size; Yaxis: relative fluorescence units (RFUs).
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CHAPTER FOUR: RESULTS
RAPID MALE SPERM IDENTIFICATION 1-STEP RT-HRM ANALYSIS

To address another major problem in current DNA workflows, a novel rapid male DNA
screening assay was developed to provide not only a way to triage sexual assault evidence but to
possibly eliminate the need for microscopic sperm ID. The assay paired a rapid lysis-based RNA
extraction with a 1-step combined RT-HRM. A rapid-RNA lysis was used to quickly extract
RNA from sample types typically found in SAKs (eg. vaginal swabs), while consuming very
little sample (tip-sized portion). The extraction permitted the waste fractions to be saved, as
studied previously, for male DNA screening and possible male profiling. This was a similar
process as previously discussed, however the process involved extracting RNA and recovering
DNA from the waste fractions. The RNA extraction was paired with a High-Resolution Melt
assay to provide a rapid detection and reduced cost alternative to CE based methods. When
combined with a reverse transcription reaction, gene-specific markers are able to be amplified in
real-time and detected with respect to their melting temperatures and distinct melt peak. To
assess the capability of integrating sperm identification by mRNA profiling into this rapid
upfront male DNA screening assay, an HRM analysis method first needed to be developed and
optimized. An initial performance and sensitivity test were performed to ensure accurate
detection of sperm using a 1-step combined RT-HRM assay to detect PRM2. Once optimized,
body fluid samples were extracted using the rapid-RNA lysis-based method and tested for the
presence of sperm using the RNA recovered from the extraction. To assess the performance of
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the assay, single-sourced semen, vaginal secretions, menstrual blood, blood and saliva samples
were extracted while saving the lysate waste. Once diluted and successfully screened for male
DNA, indicated by a male quantitation value, the RNA extracts were examined for the presence
of sperm. If there was an indication of male DNA and the presence of sperm, the waste samples
were brought forward for possible male DNA profiling. Finally, because sexual assault evidence
is the target sample type for this assay, vaginal-semen mixtures were analyzed to ensure the
assay was just as robust in the presence of multiple body fluids.

Sensitivity and Initial Primer Testing
Based on previous work with HRM, PRM2 was selected for its amplification efficiency
and sperm specificity [unpublished work, Ballantyne laboratory]. Initial HRM assay testing was
performed to determine the melting temperature (Tm) of PRM2, which was determined to be 82.5
(+ 0.5 ˚C). To test the sensitivity of PRM2 using the reduced-time Power SYBR® 1-step RTHRM assay, diluted RNA extracts from single-sourced semen samples from 2 different
individuals with known concentrations (extracted using a standard organic RNA extraction, not
the rapid lysis method) were serially diluted from 2 ng-0.1 ng of total RNA for set 1, and 2 ng 0.125 ng of total RNA for an additional two sets (different donors used in each set). The results
from the sensitivity testing are provided in Table 12. For set 1, PRM2 was not detected past 0.8
ng of input RNA. However, in set 2, PRM2 was detectable with as little as 0.125 ng of input
RNA. For set 3, PRM2 was undetectable with 0.5 ng or less of input RNA. Therefore, despite
some variation, PRM2 (i.e. sperm) was detected in as little as 0.5-0.13 ng of total RNA.
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Table 12 Melting temperatures of serially diluted single sourced semen RNA extracts to
test the sensitivity of the Power SYBR 1-Step reduced time assay
The detection of PRM2 is represented by a melting temperature (Tm) of ~82˚C and an orange
colored cell. Cells colored in gray and a melting temperature ~64˚C represent that the sample did
not detect PRM2.
Set 1

2 ng

1.6 ng

1.2 ng

0.8 ng

0.4 ng

0.2 ng

0.1 ng

CT

30.4

30.1

31.4

31.4

38.4

N/A

37.1

Tm

82.2

82.2

82.4

82.4

64.6

64.6

65.4

Set 2

2 ng

1 ng

0.5 ng

0.25 ng

0.125 ng

CT

34.1

35.5

36.4

37.0

35.9

Tm

82.1

82.5

82.5

82.6

82.6

Set 3

2 ng

1 ng

0.5 ng

0.25 ng

0.125 ng

CT

35.6

36.2

36.8

N/A

N/A

Tm

82.5

82.6

82.6

64.4

64.24

Single-Source Samples
Next, analysis was performed to determine if it was possible to 1) analyze extract waste
for male DNA for the triage of sexual-assault evidence and 2) integrate mRNA profiling into a
male sperm detection assay to eliminate the need for microscopic sperm ID. To simulate the
screening process (Figure 7), all sample waste fractions, saved from the rapid-RNA lysis-based
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Figure 7 Suggested Rapid Male DNA Screening Assay workflow

extraction, were quantified to determine if male DNA was present and was indicated by an
observed male quantitation value. Fifteen single-sourced non-vasectomized male semen swabs,
1 vasectomized male semen swab, 8 vaginal secretion swabs, and 4 menstrual blood, saliva, and
blood samples were extracted using the rapid-lysis RNA extraction and the first waste fraction
was saved for DNA analysis. For the purpose of the study, all samples were brought forward for
subsequent HRM analysis to test the capability of the assay. PRM2 was successfully detected at
the expected melting temperature for all tested semen samples and were undetected in the
vasectomized male semen, vaginal secretion, saliva, blood and menstrual blood samples that
were also tested (Table 13), thus demonstrating the specificity of the developed assay.
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Table 13 Single sourced non-vasectomized male semen, vasectomized male semen, vaginal
secretions, menstrual blood, saliva and blood samples analyzed for the presence of PRM2
using a rapid male sperm 1-step RT-HRM assay
The detection of PRM2 in single-sourced body fluid (Semen-orange, Vaginal secretions-green,
menstrual blood-pink, saliva-blue, and blood-red) samples is represented by an orange colored
cell. When PRM2 was undetected the cell is colored gray. The total number of PRM2 specific
peaks detected at ~82˚C out of the total number of samples are listed in each cell.

Semen

PRM2 Detected at
~82˚C (+/- 0.5˚C)
15/15

Semen (Vasectomized)

0/1

Vaginal

0/8

Menstrual blood

0/4

Saliva

0/4

Blood

0/4

Body Fluid

As can be seen in Figure 8 (right), a single orange melt curve can be seen at ~82˚C, representing
a positive detection of sperm-specific PRM2, compared to the melt curve (Figure 8 (left)) of a
vasectomized male (azoospermic) semen sample, representing no detection of PRM2. Next,
those samples tested positive for male DNA and/or sperm, were then subjected to downstream
DNA analysis. As described in the proposed workflow for the Rapid Male Sperm Screening
Assay (Figure 8), the lysate waste from the RNA extraction was saved and quantified. Once
diluted to ensure DTT did not inhibit PCR, Y-STR profiling was performed. All DNA waste
extractions were amplified using the Yfiler™ Plus PCR Amplification kit, which detects up to 27
potential Y-STR loci. All 27 loci were detectable in 14 out of the 15 single sourced semen
samples.
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Figure 8 High Resolution Melt graphs for two different semen donors extracted using the
rapid lysis-based RNA extraction.
Graph 1 (left) represents a vasectomized male semen sample; Graph 2 (right) represents a nonvasectomized male semen sample. Black curve-semen positive control sample; Gray curveextraction blank and negative control; Orange curve- semen sample. The X-axis represents the
temperature in Celsius and the Y-axis represents the negative first derivative of fluorescence
with respect to temperature (-dF/dT).
Table 14 shows the amount of DNA input into the amp for each sample (0.15 ng to the targeted
amount of 0.5 ng of DNA input). Those samples that do not reach the recommended amp input
have a greater chance for locus drop-out. Semen sample 25 (SE25) can be considered low-level,
with respect to male DNA, because only 0.15 ng of total DNA was amplified and as a result,
only 26 out of 27 alleles were detectable. Due to the Y-chromosome’s haploid nature, malespecific DNA may not yield a complete profile but often times the total amount of DNA is
sufficient for traditional STR profiling. Therefore, being able to also amplify autosomal STRs is
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important. In the case of SE25 a complete Y-STR profile was not obtained, but there was
sufficient total DNA present in the sample to detect a complete autosomal STR profile (Figure
9). Based on the results thus far, single sourced evidence was successfully screened for the
presence of male DNA, was able to detect sperm in non-vasectomized male semen samples and
offered the ability to obtain a male DNA profile without disrupting the flow of analysis.
Table 14 Amount of amplified male DNA with respect to the number of alleles detected for
single sourced samples successfully screened for PRM2
The total amount of male DNA amplified to target 27 Y-STRs. The number of alleles detected
out of the total detectable alleles is listed in the cells. Samples that positively detected PRM2
during HRM analysis are represented by an orange colored cell.
Sample

Total Male DNA
amplified (ng)

Number of
alleles present

SE5
SE15
SE16
SE25
SE26
SE460
SE461
SE462
SE463
SE464
SE324
SE325
SE326
SE327
SE328

0.3
0.2
0.5
0.15
0.5
0.25
0.4
0.5
0.3
0.5
0.5
0.5
0.5
0.3
0.5

27/27
27/27
27/27
26/27
27/27
27/27
27/27
27/27
27/27
27/27
27/27
27/27
27/27
27/27
27/27
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Figure 9 Autosomal STR profile obtained from the extraction waste fraction of a semen
sample extracted with rapid RNA lysis-method.
Complete 24 loci GlobalFiler™ profile when 0.15 ng of DNA is amplified and recovered from
the waste fraction of a tip-sized semen sample extracted with the Dynabeads® mRNA Direct®
kit. Loci separated by dye color: Blue Channel (6-FAM), Green Channel (VIC), Yellow Channel
(NED - shown in black), Red Channel (TAZ), Purple Channel (SID) purple; Channel Orange
(LIZ-not shown). Below each peak is the allele call, and the RFU value of the detected gene
product. X-axis: base pair (bp) size; Y-axis: relative fluorescence units (RFUs).
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Mixture Samples
To examine the capability of the screening assay to detect male DNA in sexual-assault
related evidence, admixed vaginal-semen mixtures were analyzed. Several vaginal-semen
mixtures, each with different male-female donors, were made by depositing 10, 5, 2 and 1 µL of
liquid semen onto dried vaginal swabs. Once each sample was extracted using the Dynabeads™
mRNA Direct™ mini kit and the lysis waste saved, the waste was screened for male DNA. As
expected, although there were variations between donors, as the volumes of semen decreased so
did the amount of male DNA detected. Next, HRM analysis was performed to identify the
presence of sperm in each mixture. As can be seen in Table 15, PRM2 was detectable in all of
the 10 and 5 µL semen deposits, five out of six of the 2 µL semen deposits and four out of the six
1 µL semen deposits.
Table 15 Detection of sperm in vaginal-semen mixtures with different amounts of semen
deposited onto dried vaginal swabs using the rapid male sperm assay
Each cell lists the number of samples in which sperm was successfully detected out of the total
number of mixtures analyzed with respect to the amount of semen deposited for each mixture.

Vaginal Donor

Semen 10 µL

Semen 5 µL

Semen 2 µL

Semen 1 µL

6/6

6/6

5/6

4/6

Upon melt curve analysis, there was a single peak at the expected melting temperature for the
mixtures represented in Figure 9. It should be noted that this assay is not necessarily quantitative,
and the height of a taller melt peak does not mean there has a greater quantity of RNA in the
sample when compared to a smaller peak. In Figure 10a a vaginal-semen mixture
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(a)

(b)

(c)

(d)

Figure 10 High Resolution Melt graphs for vaginal secretion-semen mixtures extracted
using the rapid lysis-based RNA extraction.
a) Vaginal-semen mixture with 10 µL of semen deposited onto a dried vaginal swab; b) vaginalsemen mixture with 5 µL of semen deposited onto a dried vaginal swab; c) vaginal-semen
mixture with 2 µL of semen deposited onto a dried vaginal swab vasectomized male semen
sample; d) vaginal-semen mixture with 1 µL of semen deposited onto a dried vaginal swab.
Black curve-semen positive control sample; Gray curve-extraction blank and negative control;
Orange curve- semen sample. The x-axis represents the temperature in Celsius and the y-axis
represents the negative first derivative of fluorescence with respect to temperature (-dF/dT).
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containing 10 µL of semen has a comparatively lower peak height than a vaginal-semen mixture
containing 1 µL of semen (Figure 10d). Based on these results, the sensitivity of this HRM assay
can possibly detect sperm in as little as 1 µL of semen but is 100% successful with as little as 5
µL, when vaginal secretion-specific RNA is present. Based on the successful detection of sperm
in mixtures containing as little as 1 µL of semen, a mixture sensitivity test was performed.
Volumes of semen ranging from 1.25-0.16 µL were deposited onto dried vaginal swabs. The
vaginal-semen donors were kept the same for this analysis. As can be seen in Table 16, while
variations between donors was observed, PRM2 was detectable in as 0.15 µL of semen using this
assay.
Table 16 Detection of Sperm specific PRM2 body fluid marker in vaginal-semen body fluid
mixtures with 0.15-1.25 µL of semen to determine the limit of detection of the 1-Step RTHRM assay
The detection of PRM2 is represented by a melting temperature (Tm) of ~82˚C and an orange
colored cell. Cells colored in gray represent samples that did not detect PRM2.
Vaginal
Donor
VS8

Semen
Donor
SE461

VS40

SE462

VS37

SE463

Volume of
Semen (µL)
1.25
0.625
0.3125
0.1563
1.25
0.625
0.3125
0.1563
1.25
0.625
0.3125
0.1563
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CT

Tm

32.9
36.8
37.0
N/A
35.5
34.3
35.3
34.8
N/A
N/A
N/A
N/A

82.1
82.3
82.3
81.8
82.3
82.5
82.7

As a result, the HRM assay has the capability to detect sperm in mock sexual-assault evidence
and in evidence that may contain very little semen in the presence of other body fluids.
Next, to determine if DNA analysis was possible in these types of samples, mixtures
successfully screened for male DNA and/or tested positive for sperm were subjected to male
DNA profiling. Table 17 lists the six different vaginal-semen mixture samples that were
analyzed with respect to the total amount of DNA inputted into the amp. The specific samples
that detected sperm are colored in orange and those that tested negative are in gray. As expected,
the samples negative for sperm also had a comparably low DNA yield. A majority of these lowlevel DNA samples obtained a complete male profile. Based on previous work with singlesourced semen samples, it is possible to positively detect sperm in a sample and unsuccessfully
detect a complete Y-STR profile in the DNA waste. Figure 11 represents the melt-curve for a
sample in which sperm was successfully detected and 0.07 ng of DNA was amplified from the
extraction waste fraction. There was not enough male DNA present in the waste to obtain a
complete male profile (Figure 12). The overall goal of this assay is not to obtain a male profile
but to be able to successfully screen samples for male DNA and possibly detect the presence of
sperm. As a result, this rapid male screening assay can successfully screen mock sexual-assault
evidence for male DNA using the waste from a rapid- lysis- based RNA extraction. This assay
has the additional benefit of being able to detect sperm and obtain a male-profile with no
modifications to the DNA workflow.
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Table 17 Number of Y-STR alleles detected in the RNA extraction waste fractions of
vaginal-semen mixtures with various amounts of semen and previously screened for sperm
The total amount of male DNA amplified to target 27 Y-STRs. The number of alleles detected
out of the total detectable alleles is listed in the cells. Samples that positively detected PRM2
during HRM analysis are represented by an orange colored cell. Samples in which PRM2 was
not detected are represented by an orange cell.
Vaginal
Donor

VS4

VS41

VS42

VS8

VS37

VS40

Semen
Donor

SE460

SE26

SE25

SE461

SE463

SE462

Volume of
Semen (µL)

Total Male DNA
amplified(ng)

Alleles
Present

10

0.3

27/27

5

0.3

27/27

2

0.07

18/27

1

0.07

23/27

10

0.5

27/27

5

0.5

27/27

2

0.5

27/27

1

0.5

27/27

10

0.1

16/27

5

0.05

14/27

2

0.01

5/27

1

0.003

5/27

10

0.5

27/27

5

0.45

27/27

2

0.25

27/27

1

0.1

27/27

10

0.5

27/27

5

0.25

27/27

2

0.1

27/27

1

0.1

26/27

10

0.5

27/27

5

0.5

27/27

2

0.35

27/27

1

0.05

27/27
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Figure 11 High Resolution Melt graphs for a vaginal-semen mixture extracted using the
rapid lysis-based RNA extraction.
1 µL of semen deposited onto dried vaginal swab and extracted using the rapid RNA lysis
method. Black curve-semen positive control sample; Gray curve-extraction blank and negative
control; Orange curve- semen sample. The x-axis represents the temperature in Celsius and the
y-axis represents the negative first derivative of fluorescence with respect to temperature
(-dF/dT).
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Figure 12 Y-STR profile obtained from the waste fraction of a vaginal-semen mixture
containing 1 µL of semen extracted with the rapid RNA lysis method.
Incomplete 25 loci YFiler™ profile when 0.07 ng of DNA is amplified and recovered from the
waste fraction of a vaginal-semen mixture containing 1 µL of semen and extracted with the
Dynabeads® mRNA Direct® kit. Dropout observed at the DYS391, DYS390, DYS438, and
DYS481 Loci. Loci separated by dye color: Blue Channel (6-FAM), Green Channel (VIC),
Yellow Channel (NED - shown in black), Red Channel (TAZ), Purple Channel (SID) purple;
Channel Orange (LIZ-not shown). Below each peak is the allele call, and the RFU value of the
detected gene product. X-axis: base pair (bp) size; Y-axis: relative fluorescence units (RFUs).
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CHAPTER FIVE: CONCLUSIONS

The main goal of this study was to provide improvements to mRNA profiling
methodologies for better integration into DNA workflows. The traditional body fluid
identification methods, still currently used by crime labs, are laborious, do not allow for
definitive identification of all forensically relevant body fluids and are not easily integrated into
DNA workflows. Therefore, crime labs want to bypass body fluid identification altogether. This
could possibly underrepresent the evidence and be detrimental in court proceedings. It is
important for investigators to determine the origin and location of a stain/tissue because it can
provide additional information surrounding the circumstances of a crime and locate potential
sources of DNA. Although many molecular-based methods for the identification of body fluids
have been studied, mRNA profiling has the most promise for potential integration into
established DNA workflows. Because mRNA profiling works by targeting the multicellular
transcriptome unique to body fluids of forensic interest, it is a sensitive and specific way to
potentially identify all relevant body fluids in biological stains. It also has the added benefits of
using modern DNA technologies, making it easily integrated into DNA workflows. While
advancements have been made, more research is needed to be done to improve mRNA profiling.
This study aimed to improve two challenges effecting DNA workflows. The first was to
provide a possible RNA recovery method that did not interfere with established DNA workflows
and the second was to integrate mRNA profiling into an upfront male DNA screening assay that
not only permitted a triage for sexual-assault evidence, by indicating the presence of potential
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male DNA, but could also potentially reduce or eliminate a significant bottleneck in the standard
DNA workflow of microscopic sperm identification. The first study was able to provide two
unique methods for recovering RNA, without modifying an established DNA extraction, using
the waste from DNA extractions and the DNA extract itself. Both of these methods permitted the
identification of blood, semen, saliva, vaginal secretions and menstrual blood when mRNA
profiling was performed using multiplex-PCR followed by capillary electrophoresis.
Additionally, both methods had no effect on DNA recovery, allowing for detection of complete
STR profiles for the samples analyzed. The second study provided a method for rapidly
screening sexual assault evidence with an upfront male DNA detection and subsequent sperm
and Y-STR detection. This method paired a rapid-lysis RNA extraction with a sensitive 1-step
combined reverse transcription-HRM assay for the detection of sperm. The extraction allows for
the waste fraction to be saved and quantified for an upfront detection of male-DNA, indicated by
a male quant value. Then the RNA extracts can be analyzed for the presence of sperm using the
HRM assay. Once samples were successfully screened for male DNA and/or detected for sperm,
the waste fraction could be sent forward for male profiling.
In the first study, several validation studies were performed to determine if mRNA
profiling was possible amongst various waste fractions and aliquots of DNA extract, sample
sizes, and forensically relevant evidence types. Body fluid detection was possible in all waste
fractions saved from a PrepFiler™ manual DNA extraction. However, the first lysis buffer/lysate
waste fraction once purified with the PureLink® RNA mini kit, permitted consistent body fluid
detection for all forensically relavent sample types. It was also discovered that RNA could be
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recovered without purification of waste fractions, using the DNA extract itself. It was believed
that mRNA also binds to the silica-based beads, during the extraction, and are eluted off of the
beads along with DNA. As little as 10 µL of DNA extract provided successful identification of
all relevant body fluids under normal conditions. To evaluate if either method allowed for
preferential body fluid identification, all validation studies were performed using both RNA
recovery methods.
In terms of sample size, half and quarter sized swabs worked best for detecting
saliva/menstrual blood and semen/vaginal secretions respectively. This was consistent amongst
both RNA recovery methods, with the exception of a single semen sample that was unidentified
using the RNA from DNA. Body fluid identification was much more variable when it came to
stain testing. Blood was successfully identified in half 50 µL stains and the equivalent 25 µL
stain using both methods. However, RNA from as little as 1 µL of blood was only successfully
recovered using the RNA from DNA. Likewise, more saliva makers were successfully identified
in the RNA from DNA than from the waste fraction. Semen was the least successfully identified
body fluid across both methods when deposited as a stain. Next, the methods were analyzed
when mock casework samples were tested. Body fluids were deposited as stains on denim,
polyester and paper were left out at room temperature for up to a year. Denim samples posed a
problem during the extraction process and resulted in decreased DNA recovery and very few
successful body fluid identifications, mainly blood, across all time points. Blood and saliva stains
on polyester were successfully identified across most time points using the RNA from DNA and
although the results varied, they were more successfully identified on paper using the RNA from
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DNA as well. Semen was successfully identified using both methods on both polyester and
paper. When the same body fluids were deposited on cotton and exposed to higher temperatures,
saliva was unidentifiable in all cases using both methods. However, semen and blood were more
successfully identified even when exposed at 56˚C for 1 month using either method. Finally,
both methods were evaluated with body fluid mixtures. It can be said that when making mixture
samples the liquids being deposited onto swabs are very viscous and the total volume does not
always get absorbed into the swab. As a result, both methods allowed for possible identification
of one or both of the two-body fluids when mixed, but the results were variable and further
analysis needs to be performed to validate if these methods can identify more than one body fluid
when present in samples.
Although there were false negative results for some body fluids, this method did not
produce any false positive identifications. Therefore, the detection of a specific allele can be
considered a positive identification whereas no detection might mean that although body fluid
identification was unsuccessful further analysis optimization (i.e. lowering analysis RFU
thresholds) could improve the number of false negative results. Based on these results, mRNA
profiling can be successfully integrated into a DNA workflow using both the DNA extraction
waste, once purified, and also directly from the DNA extract itself without the need to purify.
Integration of this method does not influence the recovery of DNA and allows for mRNA
profiling simultaneously or when necessary. Although the method is variable amongst sample
types, it has the ability to provide investigators with additional information in terms of body fluid
identification.
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In the second study, the use of the DynaBeads™ mRNA Direct™ Kit allowed for a quick
way to extract mRNA from very little sample as well as the ability to save the extraction waste
for an upfront male DNA detection. The crude RNA extracts were easily integrated into a highly
sensitive 1-step combined RT-HRM assay for the detection of sperm. Single-sourced body fluid
samples were successfully screened for the presence of male DNA and sperm could be
successfully detected using the PRM2 biomarker. Upon HRM analysis, samples containing
sperm had a single distinct melt peak around a Tm of 82˚C, which was absent when PRM2 was
not detected. The HRM assay provides a quick and sensitive way to detection of sperm without
the need to perform a laborious microscopic sperm ID. The analyst then has the ability to move
forward with DNA analysis using the remaining unused sample or using the waste fraction from
the RNA extraction that was already performed. Because the purpose of this assay was to screen
sexual-assault evidence, it was important to determine if vaginal-semen mixtures containing low
levels of semen could be successfully screened for male DNA and subsequently detect sperm and
a male DNA profile. Although variable, male DNA was detected in all extraction waste samples
and PRM2 was detectable in all vaginal-semen mixtures containing 10-5 µL of semen. These
sample waste fractions were also able to provide enough male DNA to detect a complete Y-STR
profile. Although the assay was capable of detecting male DNA in vaginal-semen mixtures
containing as little as 1 µL of semen the waste fraction did not always allow for complete Y-STR
detection. Samples that were successfully screened for PRM2 but did not recover enough DNA
in the waste fraction, can always be re-extracted using traditional methods because very little
sample was used for the screening assay.
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Although this study proved that mRNA profiling can be fully integrated into existing
DNA workflows, more optimization to both methods needs to be done. Many crime labs use an
automated DNA extraction process and cannot simply remove the waste fractions throughout the
process. The PrepFiler™ kit was designed for both a manual and automated DNA extraction, and
further validation studies need to be performed to determine if RNA can be recovered when an
automated extraction is performed. This may lead to more consistently successful body fluid
detection for those more difficult sample types. Another future study that may improve RNA
recovery in extraction waste, is to evaluate a reduced volume purification protocol. By reducing
the elution volume, the recovered RNA could in turn be more concentrated allowing for better
detection. Finally, although the HRM assay was to designed to provide a sperm ID, it is the hope
that more body fluid markers can be integrated into the assay. Current work is underway into a
duplex 1-step RT-HRM assay that can identify both seminal fluid and sperm. Although sperm is
indicative of semen, sperm is not always present in semen (azoospermic males). With the ability
to detect both seminal fluid and sperm, there would be no need to perform microscopic sperm ID
or semen specific tests such as PSA [8, 9]. The results provided in this study along with further
validation and optimization of the methods, prove the promise of integrating mRNA profiling
into DNA workflows. These advantages prove beneficial for forensic casework and provide
alternative methods for body fluid identification.
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